Alx Oncology Holdings (ALXO) Long-Term Investments (2022 - 2026)

Alx Oncology Holdings (ALXO) has 5 years of Long-Term Investments data on file, last reported at $28.8 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 214.19% year-over-year to $28.8 million; the trailing twelve-month figure through Mar 2026 stood at $28.8 million (up 214.19% YoY), and the FY2025 full-year result was $3.5 million, down 0.85% from the prior year.
• Long-Term Investments improved to $28.8 million in Q1 2026, from $3.5 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $35.4 million in Q4 2023 to a low of $3.5 million in Q4 2025.
• A 5-year average of $15.8 million and a median of $11.6 million in 2023 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments slumped 90.05% in 2024 and jumped 214.19% in 2026, its largest moves.
• Tracing ALXO's Long-Term Investments over 5 years: stood at $16.7 million in 2022, then surged by 112.05% to $35.4 million in 2023, then tumbled by 90.05% to $3.5 million in 2024, then retreated by 0.85% to $3.5 million in 2025, then jumped by 723.78% to $28.8 million in 2026.
• Business Quant data shows ALXO's Long-Term Investments at $28.8 million in Q1 2026, $3.5 million in Q4 2025, and $5.8 million in Q3 2025.